Last reviewed · How we verify

NCT06737445

Corticosteroid Injection, Extracorporeal Shock Wave Therapy, and Radiofrequency Ablation for Chronic Plantar Fasciitis:

Completed NA Last updated 19 December 2024
What this trial tests

NA trial testing Radiofrequency ablation alone in Chronic Plantar Fasciitis in 49 participants. Completed in 1 February 2023.

Timeline
1 April 2021
Primary endpoint
1 February 2023
1 February 2023

Quick facts

Lead sponsorKars Harakani State Hospital
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment49
Start date1 April 2021
Primary completion1 February 2023
Estimated completion1 February 2023
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Kars Harakani State Hospital

Who can join

Adults 18 to 75, any sex, with Chronic Plantar Fasciitis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Chronic plantar fasciitis is a prevalent condition causing persistent heel pain, often refractory to conservative treatments. This prospective randomized controlled trial aimed to compare the effectiveness of corticosteroid injection (CSI) , extracorporeal shock wave therapy (ESWT), and radiofrequency thermal lesioning (RTL) in the management of chronic plantar fasciitis.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Comparative efficacy of corticosteroid injection, extracorporeal shock wave therapy, and radiofrequency ablation for chronic plantar fasciitis: a prospective randomized controlled trial.
    Tütüncü MN, Sekizkardeş M, Şahin E, Karaismailoğlu B. · · 2026 · PMID 41593558 · DOI 10.1186/s12891-026-09542-1

Verify or expand the search:

Other trials of Radiofrequency ablation alone

Trials testing the same drug.

Other recruiting trials for Chronic Plantar Fasciitis

Currently open trials in the same condition.

Other Kars Harakani State Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06737445.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing